Narcolepsy—clinical spectrum, aetiopathophysiology, diagnosis and treatment

CLA Bassetti, A Adamantidis, D Burdakov… - Nature Reviews …, 2019 - nature.com
Narcolepsy is a rare brain disorder that reflects a selective loss or dysfunction of orexin (also
known as hypocretin) neurons of the lateral hypothalamus. Narcolepsy type 1 (NT1) is …

Association and risk factors for obstructive sleep apnea and cardiovascular diseases: a systematic review

AK Mitra, AR Bhuiyan, EA Jones - Diseases, 2021 - mdpi.com
Obstructive sleep apnea (OSA) is a serious, potentially life-threatening condition.
Epidemiologic studies show that sleep apnea increases cardiovascular diseases risk factors …

The neurobiological basis of narcolepsy

CE Mahoney, A Cogswell, IJ Koralnik… - Nature Reviews …, 2019 - nature.com
Narcolepsy is the most common neurological cause of chronic sleepiness. The discovery
about 20 years ago that narcolepsy is caused by selective loss of the neurons producing …

International consensus statement on obstructive sleep apnea

JL Chang, AN Goldberg, JA Alt… - International forum of …, 2023 - Wiley Online Library
Background Evaluation and interpretation of the literature on obstructive sleep apnea (OSA)
allows for consolidation and determination of the key factors important for clinical …

Sleep disturbance and pain: a tale of two common problems

ML Andersen, P Araujo, C Frange, S Tufik - Chest, 2018 - Elsevier
Chronic pain has been associated with sleep disturbances in a bidirectional manner, with
pain disrupting sleep, and sleep deprivation or disturbance increasing pain. This …

Update on persistent excessive daytime sleepiness in OSA

S Javaheri, S Javaheri - Chest, 2020 - Elsevier
OSA is a highly prevalent sleep disorder, and subjective excessive daytime sleepiness
(EDS) is the cardinal symptom for which many individuals seek medical advice. Positive …

Disrupted nighttime sleep and sleep instability in narcolepsy

K Maski, E Mignot, G Plazzi… - Journal of Clinical Sleep …, 2022 - jcsm.aasm.org
Study Objectives: This review aimed to summarize current knowledge about disrupted
nighttime sleep (DNS) and sleep instability in narcolepsy, including self-reported and …

[HTML][HTML] Cardiovascular disorders in narcolepsy: review of associations and determinants

PJ Jennum, G Plazzi, A Silvani, LA Surkin… - Sleep Medicine …, 2021 - Elsevier
Summary Narcolepsy type 1 (NT1) is a lifelong disorder of sleep-wake dysregulation defined
by clinical symptoms, neurophysiological findings, and low hypocretin levels. Besides a role …

Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind …

RK Bogan, MJ Thorpy, Y Dauvilliers, M Partinen… - Sleep, 2021 - academic.oup.com
Abstract Study Objectives Evaluate efficacy and safety of lower-sodium oxybate (LXB), a
novel oxybate medication with 92% less sodium than sodium oxybate (SXB). Methods …

Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation

D Latorre, F Sallusto, CLA Bassetti… - Seminars in …, 2022 - Springer
Narcolepsy is a rare chronic neurological disorder characterized by an irresistible excessive
daytime sleepiness and cataplexy. The disease is considered to be the result of the selective …